πŸ‡ΊπŸ‡Έ FDA
Patent

US 8389759

Oligomer-anticholinergic agent conjugates

granted A61KA61K47/60A61P

Quick answer

US patent 8389759 (Oligomer-anticholinergic agent conjugates) held by Nektar Therapeutics expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K47/60, A61P, A61P13/00, A61P13/06